There is still controversy about the effective of glucocorticoids for the treatment of novel coronavirus pneumonia. This is a prospective randomized controlled trails. The aim is to explore the effectiveness and safety of glucocorticoids in the treatment of novel coronavirus pneumonia.
Drug: Methylprednisolone
Methylprednisolone 1mg/kg/day ivgtt for 7 days.
Inclusion Criteria:
- age more than 18 years old
- accord with the clinical diagnosis and/ or etiological diagnosis diagnostic criteria
of Novel coronavirus pneumonia (COVID-19).
- admitted in the general wards
- be able to sign informed consent
Exclusion Criteria:
- severe immunosuppression (HIV infection, long-term use of immunosuppressive agents
- pregnant or lactation period women
- glucocorticoids are needed for other diseases
- unwilling or unable to participate or complete the study
- participate in other study
Hubei province hospital of integrated Chinese & Western Medicine
Wuhan, Hubei, China
Yichang first people's Hospital
Yichang, Hubei, China
Beijing YouAn Hospital
Beijing, China
Renmin Hospital of Wuhan University
Wuhan, China
Tianyou Hospital Affiliated to Wuhan University of science and technology
Wuhan, China
Union Hospital Affiliated to Tongji Medical College of Huazhong University of science and technology
Wuhan, China
the first peopel hospital of Xiangyang
Xiangyang, China